Cancer Stem Cell Clusters
Cancer Remains Deadly
It is medical consensus that circulating cancer stem cell clusters (i.e. metastatic cancer cell clusters) are responsible for late stage tumor metastasis.
TumorGen is developing the tools necessary to help create new drugs that specifically target metastases.
Our technology is a versatile microfluidic platform that is pioneering drug discovery against cancer stem cell clusters, the drivers of metastasis.
Our system opens up new therapeutic target spaces and enables candidate drug validation in pre-clinical ex-vivo studies, de-risking future clinical trials.